[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@PracticalNeuro Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::386755226.png) @PracticalNeuro Practical Neurology

Practical Neurology posts on X about $abbv, people with, medtronic, X months the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::386755226/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::386755226/c:line/m:interactions.svg)

- X Week XXXXX +39%
- X Month XXXXXX +1,194%
- X Months XXXXXX +24%
- X Year XXXXXX +91%

### Mentions: X [#](/creator/twitter::386755226/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::386755226/c:line/m:posts_active.svg)


### Followers: XXXXXX [#](/creator/twitter::386755226/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::386755226/c:line/m:followers.svg)

- X Week XXXXXX +0.21%
- X Month XXXXXX +0.92%
- X Months XXXXXX +4.10%
- X Year XXXXXX +7%

### CreatorRank: undefined [#](/creator/twitter::386755226/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::386755226/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::386755226/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX%

**Social topic influence**
[$abbv](/topic/$abbv) #63, [people with](/topic/people-with) #461, [medtronic](/topic/medtronic) 3.7%, [6 months](/topic/6-months) 3.7%, [longterm](/topic/longterm) XXX%

**Top accounts mentioned or mentioned by**
[@aanmember](/creator/undefined) [@mssociety](/creator/undefined) [@ectrims](/creator/undefined) [@movedisorder](/creator/undefined) [@michaeljfoxorg](/creator/undefined) [@mscare](/creator/undefined) [@novartis](/creator/undefined) [@ahsheadache](/creator/undefined) [@acpimphysicians](/creator/undefined) [@aanemorg](/creator/undefined) [@abbvie](/creator/undefined) [@nhf](/creator/undefined) [@amfmigraine](/creator/undefined) [@alzassociation](/creator/undefined) [@boveriley](/creator/undefined) [@ucsf](/creator/undefined) [@reachmd](/creator/undefined) [@theneurologyhub](/creator/undefined) [@usfda](/creator/undefined) [@medtronic](/creator/undefined)

**Top assets mentioned**
[AbbVie Inc (ABBV)](/topic/$abbv) [Medtronic PLC (MDT)](/topic/medtronic)
### Top Social Posts [#](/creator/twitter::386755226/posts)
---
Top posts by engagements in the last XX hours

"The @US_FDA has approved #Altaviva (@Medtronic) an implantable #neuromodulation device designed to treat urge urinary incontinence a symptom that can be associated with conditions like #Parkinsons #Multiple_Sclerosis #Stroke and more. @AANmember @ACPIMPhysicians"  
[X Link](https://x.com/PracticalNeuro/status/1970941648679973318) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-09-24T20:01Z 18K followers, XXX engagements


"#Botox treatment improved functional outcomes in people with upper limb essential #tremor vs placebo according to study results presented at #MDS2025. @movedisorder @MichaelJFoxOrg @essentialtremor @AbbVie"  
[X Link](https://x.com/PracticalNeuro/status/1977373983470223758) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-10-12T14:01Z 18K followers, 1881 engagements


"People with advanced idiopathic #Parkinson disease treated with #Foslevodopa/#Foscarbidopa showed improvements in motor and non-motor symptoms at X months in a study presented at #MDS2025. #Vyalev @AbbVie @Movedisorder @MichaelJFoxOrg"  
[X Link](https://x.com/PracticalNeuro/status/1977706376622223511) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-10-13T12:01Z 18K followers, XXX engagements


"Treatment with #Ultomiris (#ravulizumab) for those with #NMOSD was associated with long-term relapse prevention in data presented at #ECTRIMS2025. @ECTRIMS @AlexionPharma @AstraZeneca @mssociety"  
[X Link](https://x.com/PracticalNeuro/status/1974565347102433696) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-10-04T20:00Z 18K followers, 1149 engagements


"Results from phase X #NIMBLE trial: @Regeneron announces #cemdisiran monotherapy significantly improved MG-ADL and QMG scores in adults with generalized #Myasthenia_Gravis vs placebo. @MyastheniaOrg @AANEMorg @mssociety"  
[X Link](https://x.com/PracticalNeuro/status/1963723908357525537) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-09-04T22:00Z 18K followers, XXX engagements